Replies to post #393392 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[JRoon71]

Thanks Raf. Safe to say, I think we are pretty much in a holding pattern for the time being on US scripts.

Fortunately, we don't appear to be sliding any further.

[rafunrafun]

Scripts for week ending November 11, 2022

Drug Industry TRx: +0.1% w/w; +8.5% y/y

Vascepa
TRx 63,149; +1.1% (+711) w/w; -20.4% y/y
NRx 28,766; +0.5% (+150) w/w; -20.1% y/y
Ref 34,382; +1.7% (+561) w/w; -20.7% y/y

Fake Vascepa
TRx 41,961; +2.9% (+1,173) w/w; As % of total V: 39.9%
NRx 19,849; +3.0% (+579) w/w; As % of total V: 40.8%
Ref 22,111; +2.8% (+594) w/w; As % of total V: 39.1%

Fake Vascepa by Manufacturer
Hikma - TRx 14,990; +719 w/w; Generic share 35.7%; Total V share 14.3%
Reddy - TRx 19,143; +459 w/w; Generic share 45.6%; Total V share 18.2%
Apotex - TRx 7,641; +10 w/w; Generic share 18.2%; Total V share 7.3%
Teva - TRx 187; -13 w/w; Generic share 0.4%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 105,109; +1.8% (+1,884) w/w; +3.8% y/y
NRx 48,616; +1.5% (+729) w/w; +0.4% y/y
Ref 56,494; +2.1% (+1,155) w/w; +6.9% y/y

Lovaza (Fake & Brand)
TRx 63,556; +0.4% (+251) w/w; +1.4% y/y
NRx 31,092; +1.1% (+331) w/w; +0.9% y/y
Ref 32,464; -0.2% (-80) w/w; +1.8% y/y